The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
Open accessAbstract
Although metformin is widely used for the treatment of non-insulin-dependent diabetes, its mode of action remains unclear. Here we provide evidence that its primary site of action is through a direct inhibition of complex 1 of the respiratory chain. Metformin (50 μM) inhibited mitochondrial oxidation of glutamate+malate in hepatoma cells by 13 and 30% after 24 and 60 h exposure respectively, but succinate oxidation was unaffected. Metformin also caused time-dependent inhibition of complex 1 in isolated mitochondria, whereas in sub-mitochondrial particles inhibition was immediate but required very high metformin concentrations (K0.5, 79 mM). These data are compatible with the slow membrane-potential-driven accumulation of the positively charged drug within the mitochondrial matrix leading to inhibition of complex 1. Metformin inhibition of gluconeogenesis from L-lactate in isolated rat hepatocytes was also time- and concentration-dependent, and accompanied by changes in metabolite levels similar to those induced by other inhibitors of gluconeogenesis acting on complex 1. Freeze-clamped livers from metformin-treated rats exhibited similar changes in metabolite concentrations. We conclude that the drug's pharmacological effects are mediated, at least in part, through a time-dependent, self-limiting inhibition of the respiratory chain that restrains hepatic gluconeogenesis while increasing glucose utilization in peripheral tissues. Lactic acidosis, an occasional side effect, can also be explained in this way.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin may cause lactic acidosis through impairment of oxidative phosphorylation.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [464]
In the citing paper
“it has been shown to accumulate in mitochondria due to the membrane potential across the mitochondrial inner membrane”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Owen et al. 2000
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Owen et al., 2000
In the citing paper
“This inhibition would in turn decrease the ATP/AMP ratio activating AMPK (127–129).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“As pointed out by Fontaine, a problem associated with accepting the argument that the therapeutic effects of metformin result from inhibition of complex 1, as depicted in Figure 1, are the high concentrations used in the cell culture studies described by El Mir et al. and Owen et al. (127, 128, 133).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [210]
Citations
Cites
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 569
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227
Argaud, D., Roth, H., Wiernsperger, N. F., & Leverve, X. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17886.x · Cited by 151
Biguanide-associated lactic acidosis. Case report and review of the literature
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.11.2333 · Cited by 129
Halestrap, A. P. (1987) · Biochemical Journal · doi:10.1042/bj2440159 · Cited by 120
Self-citationFischer, Y., Thomas, J., Rosen, P., & Kammermeier, H. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835271 · Cited by 114
Cited by
Sorted by citations
Items 401–500 of 1,008
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective
Madaan, T., Akhtar, M., & Najmi, A. K. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.025 · Cited by 106
Ansari, P., Khan, J. T., Chowdhury, S., Reberio, A. D., Kumar, S., Seidel, V., Abdel‐Wahab, Y. H. A., & Flatt, P. R. (2024) · Nutrients · doi:10.3390/nu16213709 · Cited by 115
Mechanism and Treatment Related to Oxidative Stress in Neonatal Hypoxic-Ischemic Encephalopathy
Qin, X., Cheng, J., Zhong, Y., Mahgoub, O. K., Akter, F., Fan, Y., Aldughaim, M. S., Xie, Q., Qin, L., Gu, L., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00088 · Cited by 105
Rutherford, C., Speirs, C., Williams, J. J. L., Ewart, M., Mancini, S. J., Hawley, S. A., Delles, C., Viollet, B., Costa‐Pereira, A. P., Baillie, G. S., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aaf8566 · Cited by 108
Mitochondrial complex II, a novel target for anti-cancer agents
Kluckova, K., Bezawork-Geleta, A., Rohlena, J., Dong, L., & Neuzil, J. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.10.015 · Cited by 104
Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
Palmieri, G., Ombra, M. N., Colombino, M., Casula, M., Sini, M. C., Manca, A., Paliogiannis, P., Ascierto, P. A., & Cossu, A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00183 · Cited by 110
The Effect of Metformin on Insulin Resistance and Exercise Parameters in Patients with Heart Failure
Wong, A., Symon, R., AlZadjali, M. A., Ang, D. S. C., Ogston, S. A., Choy, A. M., Petrie, J. R., Struthers, A. D., & Lang, C. C. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs106 · Cited by 104
Huang, S., Yu, R.-T., Gong, J., Feng, Y., Dai, Y.-L., Hu, F., Hu, Y., Tao, Y.-D., & Leng, Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2366-3 · Cited by 104
Wang, Z., Wang, N., Liu, P., & Xie, X. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_9 · Cited by 104
LaMoia, T. E., Butrico, G. M., Kalpage, H. A., Goedeke, L., Hubbard, B. T., Vatner, D. F., Gaspar, R. C., Zhang, X., Cline, G. W., Nakahara, K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122287119 · Cited by 105
Misu, H., Takamura, T., Matsuzawa, N., Shimizu, A., Ota, T., Sakurai, M., Ando, H., Arai, K., Yamashita, T., Honda, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0489-8 · Cited by 102
Rösen, P., & Wiernsperger, N. F. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.623 · Cited by 102
Ma, R., Yi, B., Riker, A. I., & Xi, Y. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00508-0 · Cited by 104
Marycz, K., Tomaszewski, K. A., Kornicka, K., Henry, B. M., Wroński, S., Tarasiuk, J., & Marędziak, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9785890 · Cited by 102
Mitochondrial reactive oxygen species: Do they extend or shorten animal lifespan?
Sanz, A. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.018 · Cited by 111
Yang, M. H., Darwish, T., Larraufie, P., Rimmington, D., Cimino, I., Goldspink, D. A., Jenkins, B., Koulman, A., Brighton, C. A., Ma, M. K. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81349-7 · Cited by 103
Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy
Koritzinsky, M. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.003 · Cited by 103
PKA/AMPK signaling in relation to adiponectin’s antiproliferative effect on multiple myeloma cells
Medina, E. A., Oberheu, K., Polusani, S. R., Ortega, V., Velagaleti, G. V. N., & Oyajobi, B. O. (2014) · Leukemia · doi:10.1038/leu.2014.112 · Cited by 104
Moving Forwards by Blocking Back-Flow
Pell, V. R., Chouchani, E. T., Murphy, M. P., Brookes, P. S., & Krieg, T. (2016) · Circulation Research · doi:10.1161/circresaha.115.306569 · Cited by 104
OCT1 expression in adipocytes could contribute to increased metformin action in obese subjects
Moreno-Navarrete, J. M., Ortega, F. J., Rodríguez-Hermosa, J.-I., Sabater, M., Pardo, G., Ricart, W., & Fernández-Real, J. M. (2011) · Diabetes · doi:10.2337/db10-0805 · Cited by 100
Oxidative stress in metabolic diseases: current scenario and therapeutic relevance
Raut, S. K., & Khullar, M. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04496-z · Cited by 100
The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
Ye, Y., Perez-Polo, J. R., Aguilar, D. A., & Birnbaum, Y. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0216-6 · Cited by 101
Turban, S., Stretton, C., Drouin, O., Green, C., Watson, M., Gray, A., Ross, F. A., Lantier, L., Viollet, B., Hardie, D. G., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330746 · Cited by 105
Metformin in Reproductive Biology
Faure, M., Bertoldo, M. J., Khoueiry, R., Bongrani, A., Brion, F., Giulivi, C., Dupont, J., & Froment, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00675 · Cited by 103
Seo-Mayer, P. W., Thulin, G., Zhang, L., Alves, D. S., Ardito, T. A., Kashgarian, M. J., & Caplan, M. J. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00420.2010 · Cited by 102
Kane, D. A., Anderson, E. J., Price, J. W., Woodlief, T. L., Lin, C.-T., Bikman, B. T., Cortright, R. N., & Neufer, P. D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.022 · Cited by 99
Detaille, D., Vial, G., Borel, A.-L., Cottet-Rouselle, C., Hallakou-Bozec, S., Bolze, S., Fouqueray, P., & Fontaine, E. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.72 · Cited by 99
Triggle, C. R., & Ding, H. (2015) · Acta Physiologica · doi:10.1111/apha.12644 · Cited by 101
Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases
Simmons, E. C., Scholpa, N. E., & Schnellmann, R. G. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113309 · Cited by 100
Metformin and metabolic diseases: a focus on hepatic aspects
Zheng, J., Woo, S., Hu, X., Botchlett, R. E., Chen, L., Huo, Y., & Wu, C. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0384-0 · Cited by 101
Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels
Anedda, A., Rial, E., & González-Barroso, M. M. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0278 · Cited by 98
Vázquez‐Martín, A., Vellón, L., Quirós, P. M., Cufí, S., de Galarreta, E. R., Oliveras‐Ferraros, C., Martín, Á. G., Martı́n-Castillo, B., López-Otı́n, C., & Menéndez, J. A. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19450 · Cited by 98
Targeting LKB1 in Cancer – Exposing and Exploiting Vulnerabilities
Momcilovic, M., & Shackelford, D. B. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.261 · Cited by 97
Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating Oxidative Phosphorylation
Haq, R., Fisher, D. E., & Widlund, H. R. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0898 · Cited by 99
Metformin and Prostate Cancer: a New Role for an Old Drug
Whitburn, J., Edwards, C. M., & Sooriakumaran, P. (2017) · Current Urology Reports · doi:10.1007/s11934-017-0693-8 · Cited by 98
Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
Xu, S., Yang, Z., Jin, P., Yang, X., Li, X., Xiao, W., Wang, Y., Long, S., Zhang, T., Chen, G., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0927 · Cited by 100
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Martino, A. D., Albanese, G., Marfella, R., Sardu, C., et al. (2021) · Biomolecules · doi:10.3390/biom11121834 · Cited by 99
Détaille, D., Guigas, B., Leverve, X. M., Wiernsperger, N. F., & Devos, P. E. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00858-4 · Cited by 100
Lopez, M., Lax, A., Pascual-Figal, D. A., Valdés, M., & Sánchez‐Más, J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.015 · Cited by 99
Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver
Takamura, T., Misu, H., Ota, T., & Kaneko, S. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0228 · Cited by 96
Park, J., Shim, J., Kang, J. H., Choi, J., Chang, J. H., Kim, S., & Kang, S. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox243 · Cited by 96
Metabolic Effects of Metformin in the Failing Heart
Dziubak, A., Wójcicka, G., Wojtak, A., & Bełtowski, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102869 · Cited by 99
Gabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 101
Skwarski, M., McGowan, D. R., Belcher, E., Chiara, F., Stavroulias, D., McCole, M., Derham, J. L., Chu, K.-Y., Teoh, E., Chauhan, J. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4128 · Cited by 98
Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene
Krausová, L., Stejskalová, L., Wang, H., Vrzal, R., Dvořák, Z., Mani, S., & Pávek, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.023 · Cited by 97
AMPK: An emerging target for modification of injury-induced pain plasticity
Price, T. J., & Dussor, G. O. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.060 · Cited by 97
Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview
Correia, S. C., Carvalho, C., Santos, M. S., Seiça, R. M. F., Oliveira, C. R., & Moreira, P. I. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369546 · Cited by 98
Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma
Jiang, W., Finniss, S., Cazacu, S., Xiang, C., Brodie, Z., Mikkelsen, T., Poisson, L., Shackelford, D. B., & Brodie, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10919 · Cited by 101
Fitzgerald, J. C., Zimprich, A. A., Berrio, D. A. C., Schindler, K. M., Maurer, B., Schulte, C., Bus, C., Hauser, A., Kübler, M., Lewin, R., et al. (2017) · Brain · doi:10.1093/brain/awx202 · Cited by 96
AMPK Function in Mammalian Spermatozoa
Martín‐Hidalgo, D., de Llera, A. H., Calle-Guisado, V., González‐Fernández, L., Garcı́a, L. J., & Bragado, M. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113293 · Cited by 100
Current nutritional and pharmacological anti-aging interventions
Ros, M., & Carrascosa, J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165612 · Cited by 86
The wHole Story About Fenestrations in LSEC
Szafranska, K., Kruse, L. D., Holte, C. F., McCourt, P., & Zapotoczny, B. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.735573 · Cited by 105
Yang, J., & Holman, G. D. (2006) · Endocrinology · doi:10.1210/en.2005-1433 · Cited by 95
Lin, H., Li, N., He, H., Ying, Y., Sunkara, S., Luo, L., Lv, N., Huang, D., & Luo, Z. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099549 · Cited by 96
Regulation of AMPK by the Ubiquitin Proteasome System
Zungu, M., Schisler, J. C., Essop, M. F., McCudden, C. R., Patterson, C., & Willis, M. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.030 · Cited by 96
ONC201 kills breast cancer cells in vitro by targeting mitochondria
Greer, Y. E., Porat‐Shliom, N., Nagashima, K., Stuelten, C. H., Crooks, D., Kopardé, V. N., Gilbert, S. F., Islam, C., Ubaldini, A., Ji, Y., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24862 · Cited by 95
Yue, W., Zheng, X., Lin, Y., Yang, C. S., Xu, Q., Carpizo, D. R., Huang, H., DiPaola, R. S., & Tan, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4126 · Cited by 95
Cnop, M., Mulder, H., & Igoillo‐Esteve, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12216 · Cited by 99
Arunachalam, G., Lakshmanan, A. P., Samuel, S. M., Triggle, C. R., & Ding, H. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226894 · Cited by 93
Austad, S. N., Ballinger, S. W., Buford, T. W., Carter, C. S., Smith, D. L., Darley-Usmar, V. M., & Zhang, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.014 · Cited by 94
Galdieri, L. C., Gatla, H. R., Vancurova, I., & Vančura, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.742247 · Cited by 96
Thiazolidinediones: metabolic actions in vitro
Fürnsinn, C., & Waldhäusl, W. K. (2002) · Diabetologia · doi:10.1007/s00125-002-0899-1 · Cited by 94
The Role and Mechanism of Metformin in Inflammatory Diseases
Lin, H., Ao, H., Guo, G., & Liu, M. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s436147 · Cited by 96
Sebastião, I., Candeias, E., Santos, M. S., Oliveira, C. R., Moreira, P. I., & Duarte, A. I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00110 · Cited by 96
Ota, S., Horigome, K., Ishii, T., Nakai, M., Hayashi, K., Kawamura, T., Kishino, A., Taiji, M., & Kimura, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.164 · Cited by 94
The prince and the pauper. A tale of anticancer targeted agents
Dueñas‐González, A., García‐López, P., Herrera, L. A., Medina‐Franco, J. L., González‐Fierro, A., & Candelaria, M. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-82 · Cited by 94
Metformin: New Preparations and Nonglycemic Benefits
Fujita, Y., & Inagaki, N. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0829-8 · Cited by 91
AMPK: a master energy regulator for gonadal function
Bertoldo, M. J., Faure, M., Dupont, J., & Froment, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00235 · Cited by 94
Mitochondrial function in ageing: coordination with signalling and transcriptional pathways
Yin, F., Sancheti, H., Liu, Z., & Cadenas, E. (2015) · The Journal of Physiology · doi:10.1113/jp270541 · Cited by 93
GAO, Z.-Y., Liu, Z., Bi, M., Zhang, J., Han, Z., Han, X., WANG, H.-Y., Sun, G., & Liu, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3143 · Cited by 93
Targeting Mitochondria in Diabetes
Jakovljevic, N. K., Pavlović, K., Jotić, A., Lalic, K. S., Stoiljkovic, M. M., Lukić, L., Milicic, T. J., Macesic, M. V., Gajović, J. S., & Lalic, N. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126642 · Cited by 91
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
Agostini, F., Masato, A., Bubacco, L., & Bisaglia, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010398 · Cited by 90
Jensen, J., Sundelin, E. I. O., Jakobsen, S., Gormsen, L. C., Munk, O. L., Frøkiær, J., & Jessen, N. (2016) · Diabetes · doi:10.2337/db16-0032 · Cited by 91
Marini, C., Ravera, S., Buschiazzo, A., Bianchi, G., Orengo, A. M., Bruno, S., Bottoni, G., Emionite, L., Pastorino, F., Monteverde, E., et al. (2016) · Scientific Reports · doi:10.1038/srep25092 · Cited by 92
Gupta, P., Bala, M., Gupta, S. K., Dua, A., Dabur, R., Injeti, E. R., & Mittal, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.029 · Cited by 92
Lipid Accumulation in HepG2 Cells Is Attenuated by Strawberry Extract through AMPK Activation
Forbes-Hernández, T. Y., Giampieri, F., Gasparrini, M., Afrin, S., Mazzoni, L., Cordero, M. D., Mezzetti, B., Quiles, J. L., & Battino, M. A. (2017) · Nutrients · doi:10.3390/nu9060621 · Cited by 91
Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model
Shibao, S., Minami, N., Koike, N., Fukui, N., Yoshida, K., Saya, H., & Sampetrean, O. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox170 · Cited by 96
Xu, C., Liu, W., Zhang, D., Cao, X., Shi, H., & Li, X. (2017) · Aquaculture · doi:10.1016/j.aquaculture.2017.10.022 · Cited by 91
Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems
Tavakol, S., Ashrafizadeh, M., Deng, S., Azarian, M., Abdoli, A., Motavaf, M., Poormoghadam, D., Khanbabaei, H., Afshar, E. G., Mandegary, A., et al. (2019) · Biomolecules · doi:10.3390/biom9100530 · Cited by 92
A Comprehensive Review of Drug–Drug Interactions with Metformin
Stage, T. B., Brøsen, K., & Christensen, M. M. H. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0270-6 · Cited by 92
Metformin improves cardiac function in rats via activation of AMP‐activated protein kinase
Wang, X., Zhang, J., Li, L., Zhao, X., Tao, H., & Zhang, L. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05470.x · Cited by 89
Lee, J., Choi, J., Alpergin, E. S. S., Zhao, L., Härtung, T., Scafidi, S., Riddle, R. C., & Wolfgang, M. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.080 · Cited by 92
Rahimi‐Madiseh, M., Heidarian, E., Kheiri, S., & Rafieian‐Kopaei, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.028 · Cited by 88
Metformin as Potential Therapy for High-Grade Glioma
Mazurek, M., Litak, J., Kamieniak, P., Kulesza, B., Jonak, K. E., Baj, J., & Grochowski, C. (2020) · Cancers · doi:10.3390/cancers12010210 · Cited by 90
Li, H., Ding, X., Terkeltaub, R. A., Lin, H., Zhang, Y., Zhou, B., He, K., Li, K., Liu, Z., Wei, J., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2129-y · Cited by 89
The gut microbiome and type 2 diabetes status in the Multiethnic Cohort
Maskarinec, G., Raquinio, P., Kristal, B. S., Setiawan, V. W., Wilkens, L. R., Franke, A. A., Lim, U., Marchand, L. L., Randolph, T. W., Lampe, J. W., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250855 · Cited by 91
Duong, J. K., Furlong, T. J., Roberts, D. M., Graham, G. G., Greenfield, J. R., Williams, K. M., & Day, R. O. (2013) · Drug Safety · doi:10.1007/s40264-013-0038-6 · Cited by 91
Yoon, S. H., Han, E. J., Sung, J. H., & Chung, S. H. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2196 · Cited by 90
Yu, C., Jiao, Y., Xue, J., Zhang, Q., Yang, H., Xing, L., Chen, G., Wu, J., Zhang, S., Zhu, W., et al. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.18830 · Cited by 88
Metformin for treatment of fragile X syndrome and other neurological disorders
Gantois, I., Popic, J., Khoutorsky, A., & Sonenberg, N. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-081117-041238 · Cited by 87
Activation of the AMP-Activated Protein Kinase Reduces Inflammatory Nociception
Russe, O. Q., Möser, C. V., Kynast, K. L., King-Himmelreich, T. S., Stephan, H., Geißlinger, G., & Niederberger, E. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.05.012 · Cited by 87
Rogacka, D., Audzeyenka, I., Rychłowski, M., Rachubik, P., Szrejder, M., Angielski, S., & Piwkowska, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.014 · Cited by 87
Fulgencio, J.-P., Kohl, C., Girard, J. R., & Pégorier, J. P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00679-7 · Cited by 87
Soraya, H., Khorrami, A., Garjani, A., Maleki‐Dizaji, N., & Garjani, A. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70945-3 · Cited by 87
Kristensen, J. M., Treebak, J. T., Schjerling, P., Goodyear, L. J., & Wojtaszewski, J. F. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00417.2013 · Cited by 89
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 88
Is metformin poised for a second career as an antimicrobial?
Malik, F. R., Mehdi, S. F., Ali, H., Patel, P., Basharat, A., Kumar, A., Ashok, F., Stein, J., Brima, W., Malhotra, P., et al. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2975 · Cited by 89
Pleiotropic Effects of Metformin on Cancer
Schulten, H.-J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102850 · Cited by 87
Biguanides: Species with versatile therapeutic applications
Kathuria, D., Raul, A. D., Wanjari, P. J., & Bharatam, P. V. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113378 · Cited by 87
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy
Jayaprakash, P., Vignali, P., Delgoffe, G. M., & Curran, M. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-060619-022830 · Cited by 87
Metadata
- Authors
- OWEN, M. R., DORAN, E., & HALESTRAP, A. P.
- Affiliations
- University of Bristol (GB)
- ORCID
- HALESTRAP, Andrew P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-06-07
- Volume
- 348
- Issue
- 3
- Pages
- 607-614
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221104
- OpenAlex
- W1995069275
- Cited by
- 2,157
- References
- 35
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 92 · 2023: 125 · 2022: 127 · 2021: 157 · 2020: 163 · 2019: 144 · 2018: 142 · 2017: 144 · 2016: 139 · 2015: 126 · 2014: 135 · 2013: 112 · 2012: 75
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, mitochondrial complex I inhibition, mitochondrial respiratory chain, type 2 diabetes, gluconeogenesis, hepatocytes, mitochondrial membrane potential, lactic acidosis, glucose utilization, mechanism of action
- MeSH terms
- Animals, Electron Transport, Gluconeogenesis, Hypoglycemic Agents, Liver, Male, Metformin, Mitochondria, NADH, NADPH Oxidoreductases, Submitochondrial Particles, Tumor Cells, Cultured, Signal Transduction, Rats, Wistar, Electron Transport Complex I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
